drugset / Trial / NCT00654940

A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients

NCT00654940

Phase 1 Completed 25 enrolled Viatris Inc.
RandomizedCrossoverDouble-blindOther

Summary

The purpose of this study is to assess whether a cross-over type study design in post-traumatic neuropathic patients can be used to assess the activity of potential analgesic agents

Timeline

Start
2008-05
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 75 mg Oral
Comparator Pregabalin Small molecule 150 mg Oral